findmyKOL
Clinical trialNCT00528437CompletedPhase 2Interventional

Temozolomide,Thiotepa and Carboplatin With Autologous Stem Cell Rescue Followed by 13-cis-retinoic Acid in Patients With Recurrent/Refractory Malignant Brain Tumors

SponsorNYU Langone HealthEnrollment46Brain Tumors
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

17 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Canada
  • Princess Margaret Hospital

    Toronto, Ontario, Canada

United States
  • Phoenix Children'S Hospital

    Phoenix, Arizona, United States

  • Emory University

    Atlanta, Georgia, United States

  • Hawaii Pacific Health

    Lihue, Hawaii, United States

  • Children'S Memorial Hospital

    Chicago, Illinois, United States

  • Riley Hospital for Children

    Indianapolis, Indiana, United States

  • Children'S Hospital and Clinics of Minnesota

    Minneapolis, Minnesota, United States

  • Roswell Park Cancer Institute

    Buffalo, New York, United States

  • Steven and Alexandra Cohen Children'S Medical Center of New York- North Shore Lij

    New Hyde Park, New York, United States

  • Nyu Hassenfeld Center

    New York, New York, United States

  • Nationwide Children'S Hospital

    Columbus, Ohio, United States

  • Children'S Hospital of Philadelphia

    Philadelphia, Pennsylvania, United States

  • Medical Univ. of South Carolina

    Charleston, South Carolina, United States

  • Vanderbilt Univ.

    Nashville, Tennessee, United States

  • Children'S Medical Center of Dallas

    Dallas, Texas, United States

  • Md Anderson Cancer Center (mdacc)

    Houston, Texas, United States

  • Virginia Commonwealth Univ.

    Richmond, Virginia, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Oct 2005
Primary completion
30 Jun 2017
Completion
30 Dec 2017
Last update posted
8 Jul 2021
Registered enrollment
46
Registry id
NCT00528437

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.